-
1
-
-
0034958947
-
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care
-
Angus D.C., Linde-Zwirble W.T., Lidicker J., et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29 (2001) 1303-1310
-
(2001)
Crit Care Med
, vol.29
, pp. 1303-1310
-
-
Angus, D.C.1
Linde-Zwirble, W.T.2
Lidicker, J.3
-
2
-
-
10344258702
-
Occurrence of serious bacterial infections since the introduction of antibacterial agents
-
Finland M., Jones W.F., and Barnes M.W. Occurrence of serious bacterial infections since the introduction of antibacterial agents. JAMA 84 (1959) 2188-2197
-
(1959)
JAMA
, vol.84
, pp. 2188-2197
-
-
Finland, M.1
Jones, W.F.2
Barnes, M.W.3
-
3
-
-
0017029952
-
Effect of antibiotics on mortality from infectious diseases in Sweden and Finland
-
Hemminki E., and Paakkulainen A. Effect of antibiotics on mortality from infectious diseases in Sweden and Finland. Am J Public Health 66 (1976) 1180-1184
-
(1976)
Am J Public Health
, vol.66
, pp. 1180-1184
-
-
Hemminki, E.1
Paakkulainen, A.2
-
4
-
-
0018834461
-
Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients
-
Kreger B.E., Craven D.E., and McCabe W.R. Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med 68 (1980) 344-355
-
(1980)
Am J Med
, vol.68
, pp. 344-355
-
-
Kreger, B.E.1
Craven, D.E.2
McCabe, W.R.3
-
5
-
-
0037451929
-
The epidemiology of sepsis in the United States from 1979 through 2000
-
Martin G.S., Mannino D.M., Eaton S., et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348 (2003) 1546-1554
-
(2003)
N Engl J Med
, vol.348
, pp. 1546-1554
-
-
Martin, G.S.1
Mannino, D.M.2
Eaton, S.3
-
7
-
-
0032433470
-
Has the mortality of septic shock changed with time
-
Friedman G., Silva E., and Vincent J.L. Has the mortality of septic shock changed with time. Crit Care Med 26 (1998) 2078-2086
-
(1998)
Crit Care Med
, vol.26
, pp. 2078-2086
-
-
Friedman, G.1
Silva, E.2
Vincent, J.L.3
-
8
-
-
33744527833
-
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock
-
Kumar A., Roberts D., Wood K.E., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34 (2006) 1589-1596
-
(2006)
Crit Care Med
, vol.34
, pp. 1589-1596
-
-
Kumar, A.1
Roberts, D.2
Wood, K.E.3
-
9
-
-
0031472414
-
Quality of care, process, and outcomes in elderly patients with pneumonia
-
Meehan T.P., Fine M.J., Krumholz H.M., et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 278 (1997) 2080-2084
-
(1997)
JAMA
, vol.278
, pp. 2080-2084
-
-
Meehan, T.P.1
Fine, M.J.2
Krumholz, H.M.3
-
10
-
-
0141610906
-
The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting
-
Ibrahim E.H., Sherman G., Ward S., et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118 (2000) 146-155
-
(2000)
Chest
, vol.118
, pp. 146-155
-
-
Ibrahim, E.H.1
Sherman, G.2
Ward, S.3
-
11
-
-
0032911760
-
Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients
-
Kollef M.H., Sherman G., Ward S., et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115 (1999) 462-474
-
(1999)
Chest
, vol.115
, pp. 462-474
-
-
Kollef, M.H.1
Sherman, G.2
Ward, S.3
-
12
-
-
0034457796
-
Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients
-
Kollef M.H. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 31 Suppl 4 (2000) S131-S138
-
(2000)
Clin Infect Dis
, vol.31
, Issue.SUPPL. 4
-
-
Kollef, M.H.1
-
13
-
-
2142760947
-
Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'
-
Drusano G.L. Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'. Nat Rev Microbiol 2 (2004) 289-300
-
(2004)
Nat Rev Microbiol
, vol.2
, pp. 289-300
-
-
Drusano, G.L.1
-
14
-
-
0036229241
-
Pharmacological principles of antibiotic prescription in the critically ill
-
Pinder M., Bellomo R., Lipman J., et al. Pharmacological principles of antibiotic prescription in the critically ill. Anaesth Intensive Care 30 (2002) 134-144
-
(2002)
Anaesth Intensive Care
, vol.30
, pp. 134-144
-
-
Pinder, M.1
Bellomo, R.2
Lipman, J.3
-
15
-
-
0033984889
-
New pharmacodynamic parameters for antimicrobial agents
-
Li R.C. New pharmacodynamic parameters for antimicrobial agents. Int J Antimicrob Agents 13 (2000) 229-235
-
(2000)
Int J Antimicrob Agents
, vol.13
, pp. 229-235
-
-
Li, R.C.1
-
16
-
-
0028275580
-
Principles of antibiotic therapy
-
Solomkin J.S., and Miyagawa C.I. Principles of antibiotic therapy. Surg Clin North Am 74 3 (1994) 497-517
-
(1994)
Surg Clin North Am
, vol.74
, Issue.3
, pp. 497-517
-
-
Solomkin, J.S.1
Miyagawa, C.I.2
-
17
-
-
0031952586
-
Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men
-
Craig W.A. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 26 (1998) 1-10
-
(1998)
Clin Infect Dis
, vol.26
, pp. 1-10
-
-
Craig, W.A.1
-
18
-
-
0023614450
-
Inadequacy of standard aminoglycoside loading doses in acutely ill patients
-
Chelluri L., and Jastremski M.S. Inadequacy of standard aminoglycoside loading doses in acutely ill patients. Crit Care Med 15 (1987) 1143-1145
-
(1987)
Crit Care Med
, vol.15
, pp. 1143-1145
-
-
Chelluri, L.1
Jastremski, M.S.2
-
19
-
-
0242266613
-
Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis
-
Harbarth S., Garbino J., Pugin J., et al. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 115 (2003) 529-535
-
(2003)
Am J Med
, vol.115
, pp. 529-535
-
-
Harbarth, S.1
Garbino, J.2
Pugin, J.3
-
20
-
-
0019977180
-
Anti-anaerobic antibacterial agents
-
Bartlett J.G. Anti-anaerobic antibacterial agents. Lancet 2 8296 (1982) 478-481
-
(1982)
Lancet
, vol.2
, Issue.8296
, pp. 478-481
-
-
Bartlett, J.G.1
-
21
-
-
0017162278
-
Therapy of neutropenic rats infected with pseudomonas aeruginosa
-
Lumish R.M., and Norden C.W. Therapy of neutropenic rats infected with pseudomonas aeruginosa. J Infect Dis 133 (1976) 538-547
-
(1976)
J Infect Dis
, vol.133
, pp. 538-547
-
-
Lumish, R.M.1
Norden, C.W.2
-
22
-
-
0035522333
-
Infective endocarditis in adults
-
Mylonakis E., and Calderwood S.B. Infective endocarditis in adults. N Engl J Med 345 18 (2001) 1318-1330
-
(2001)
N Engl J Med
, vol.345
, Issue.18
, pp. 1318-1330
-
-
Mylonakis, E.1
Calderwood, S.B.2
-
23
-
-
77049168380
-
Antibiotic therapy of bacterial endocarditis: VI. Subacute enterococcal endocarditis: clinical, pathologic and therapeutic consideration of 33 cases
-
Geraci J.E., and Martin W.J. Antibiotic therapy of bacterial endocarditis: VI. Subacute enterococcal endocarditis: clinical, pathologic and therapeutic consideration of 33 cases. Circulation 10 (1954) 173-194
-
(1954)
Circulation
, vol.10
, pp. 173-194
-
-
Geraci, J.E.1
Martin, W.J.2
-
24
-
-
0347948546
-
Infective endocarditis
-
Moreillon P., and Que Y.A. Infective endocarditis. Lancet 363 9403 (2004) 139-149
-
(2004)
Lancet
, vol.363
, Issue.9403
, pp. 139-149
-
-
Moreillon, P.1
Que, Y.A.2
-
25
-
-
0020107992
-
Synergistic combinations of antibiotics in gram-negative bacillary infections
-
Klastersky J., and Zinner S.H. Synergistic combinations of antibiotics in gram-negative bacillary infections. Rev Infect Dis 4 (1982) 294-301
-
(1982)
Rev Infect Dis
, vol.4
, pp. 294-301
-
-
Klastersky, J.1
Zinner, S.H.2
-
26
-
-
0037563090
-
Beta-lactam monotherapy versus b-lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis
-
Paul M., Soares-Weiser K., and Leibovici L. Beta-lactam monotherapy versus b-lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis. Br Med J 326 (2003) 1111-1118
-
(2003)
Br Med J
, vol.326
, pp. 1111-1118
-
-
Paul, M.1
Soares-Weiser, K.2
Leibovici, L.3
-
27
-
-
4043059435
-
Does combination antimicrobial therapy reduce mortality in gram-negative bacteraemia? A meta-analysis
-
Safdar N., Handelsman J., Maki D.G., et al. Does combination antimicrobial therapy reduce mortality in gram-negative bacteraemia? A meta-analysis. Lancet Infect Dis 4 (2004) 519-527
-
(2004)
Lancet Infect Dis
, vol.4
, pp. 519-527
-
-
Safdar, N.1
Handelsman, J.2
Maki, D.G.3
-
28
-
-
34447126309
-
Pharmacokinetics and pharmacodynamics of antimicrobials
-
Drusano G.L. Pharmacokinetics and pharmacodynamics of antimicrobials. Clin Infect Dis 45 Suppl 1 (2007) S89-95
-
(2007)
Clin Infect Dis
, vol.45
, Issue.SUPPL. 1
-
-
Drusano, G.L.1
-
29
-
-
62849095029
-
Pharmacokinetic issues for antibiotics in the critically ill patient
-
quiz 859
-
Roberts J.A., and Lipman J. Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 37 3 (2009) 840-851 quiz 859
-
(2009)
Crit Care Med
, vol.37
, Issue.3
, pp. 840-851
-
-
Roberts, J.A.1
Lipman, J.2
-
30
-
-
50349092141
-
Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients?
-
Roberts J.A., Lipman J., Blot S., et al. Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients?. Curr Opin Crit Care 14 4 (2008) 390-396
-
(2008)
Curr Opin Crit Care
, vol.14
, Issue.4
, pp. 390-396
-
-
Roberts, J.A.1
Lipman, J.2
Blot, S.3
-
31
-
-
33748103189
-
Cure of persistent, post-appendectomy Klebsiella pneumoniae septicaemia with continuous intravenous administration of meropenem
-
Falagas M.E., Siempos I.I., and Tsakoumis I. Cure of persistent, post-appendectomy Klebsiella pneumoniae septicaemia with continuous intravenous administration of meropenem. Scand J Infect Dis 38 (2006) 807-810
-
(2006)
Scand J Infect Dis
, vol.38
, pp. 807-810
-
-
Falagas, M.E.1
Siempos, I.I.2
Tsakoumis, I.3
-
32
-
-
0026447603
-
Continuous infusion of beta-lactam antibiotics
-
Craig W.A., and Ebert S.C. Continuous infusion of beta-lactam antibiotics. Antimicrob Agents Chemother 36 (1992) 2577-2583
-
(1992)
Antimicrob Agents Chemother
, vol.36
, pp. 2577-2583
-
-
Craig, W.A.1
Ebert, S.C.2
-
33
-
-
0018664845
-
A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients
-
Bodey G.P., Ketchel S.J., and Rodriguez V. A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients. Am J Med 67 (1979) 608-616
-
(1979)
Am J Med
, vol.67
, pp. 608-616
-
-
Bodey, G.P.1
Ketchel, S.J.2
Rodriguez, V.3
-
34
-
-
0035916299
-
Antibiotic resistance in the intensive care unit
-
Kollef M.H., and Fraser V.J. Antibiotic resistance in the intensive care unit. Ann Intern Med 134 4 (2001) 298-314
-
(2001)
Ann Intern Med
, vol.134
, Issue.4
, pp. 298-314
-
-
Kollef, M.H.1
Fraser, V.J.2
-
35
-
-
4043112107
-
Pathogens resistant to antimicrobial agents: epidemiology, molecular mechanisms, and clinical management
-
Kaye K.S., Engemann J.J., Fraimow H.S., et al. Pathogens resistant to antimicrobial agents: epidemiology, molecular mechanisms, and clinical management. Infect Dis Clin North Am 18 3 (2004) 467-511
-
(2004)
Infect Dis Clin North Am
, vol.18
, Issue.3
, pp. 467-511
-
-
Kaye, K.S.1
Engemann, J.J.2
Fraimow, H.S.3
-
37
-
-
0021963387
-
Microbial resistance to newer generation beta-lactam antibiotics: clinical and laboratory implications
-
Sanders C.C., and Sanders Jr. W.E. Microbial resistance to newer generation beta-lactam antibiotics: clinical and laboratory implications. J Infect Dis 151 3 (1985) 399-406
-
(1985)
J Infect Dis
, vol.151
, Issue.3
, pp. 399-406
-
-
Sanders, C.C.1
Sanders Jr., W.E.2
-
38
-
-
33751014305
-
Clinical approach to antibiotic failure
-
Schlossberg D. Clinical approach to antibiotic failure. Med Clin North Am 90 6 (2006) 1265-1277
-
(2006)
Med Clin North Am
, vol.90
, Issue.6
, pp. 1265-1277
-
-
Schlossberg, D.1
-
39
-
-
0000688966
-
Treatment of pneumoccic meningitis with penicillin compared with penicillin plus aureomycin. Studies including observations on an apparent antagonism between penicillin and aureomycin
-
Lepper M.H., and Dowling H.F. Treatment of pneumoccic meningitis with penicillin compared with penicillin plus aureomycin. Studies including observations on an apparent antagonism between penicillin and aureomycin. Arch Intern Med 88 (1951) 489-494
-
(1951)
Arch Intern Med
, vol.88
, pp. 489-494
-
-
Lepper, M.H.1
Dowling, H.F.2
-
40
-
-
0033658368
-
Antibiotic synergy and antagonism
-
Acar J.F. Antibiotic synergy and antagonism. Med Clin North Am 84 6 (2000) 1391-1406
-
(2000)
Med Clin North Am
, vol.84
, Issue.6
, pp. 1391-1406
-
-
Acar, J.F.1
-
41
-
-
0018092864
-
Antibiotic antagonism and synergy
-
Matthews T. Antibiotic antagonism and synergy. Lancet 2 8085 (1978) 376-377
-
(1978)
Lancet
, vol.2
, Issue.8085
, pp. 376-377
-
-
Matthews, T.1
-
42
-
-
0027251106
-
Synergy and antagonism of fluoroquinolones with other classes of antimicrobial agents
-
Neu H.C. Synergy and antagonism of fluoroquinolones with other classes of antimicrobial agents. Drugs 45 Suppl 3 (1993) 54-58
-
(1993)
Drugs
, vol.45
, Issue.SUPPL. 3
, pp. 54-58
-
-
Neu, H.C.1
-
43
-
-
70350580290
-
Initiation of inappropriate antimicrobial therapy results in a 5-fold reduction of survival in human septic shock
-
in press
-
Kumar A., Ellis P., Arabi Y., et al. Initiation of inappropriate antimicrobial therapy results in a 5-fold reduction of survival in human septic shock. Chest (2009) in press
-
(2009)
Chest
-
-
Kumar, A.1
Ellis, P.2
Arabi, Y.3
-
44
-
-
0017615812
-
Gram-negative rod bacteremia: microbiologic, immunologic, and therapeutic considerations
-
Young L.S., Martin W.J., Meyer R.D., et al. Gram-negative rod bacteremia: microbiologic, immunologic, and therapeutic considerations. Ann Intern Med 86 (1977) 456-471
-
(1977)
Ann Intern Med
, vol.86
, pp. 456-471
-
-
Young, L.S.1
Martin, W.J.2
Meyer, R.D.3
-
45
-
-
0029583905
-
Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus
-
Romero-Vivas J., Rubio M., Fernandez C., et al. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 21 (1995) 1417-1423
-
(1995)
Clin Infect Dis
, vol.21
, pp. 1417-1423
-
-
Romero-Vivas, J.1
Rubio, M.2
Fernandez, C.3
-
46
-
-
0028806984
-
Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study
-
Nguyen M.H., Peacock Jr. J.E., Tanner D.C., et al. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. Arch Intern Med 155 (1995) 2429-2435
-
(1995)
Arch Intern Med
, vol.155
, pp. 2429-2435
-
-
Nguyen, M.H.1
Peacock Jr., J.E.2
Tanner, D.C.3
-
47
-
-
0035797914
-
Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. A prospective multicenter study
-
Vergis E.N., Hayden M.K., Chow J.W., et al. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. A prospective multicenter study. Ann Intern Med 135 (2001) 484-492
-
(2001)
Ann Intern Med
, vol.135
, pp. 484-492
-
-
Vergis, E.N.1
Hayden, M.K.2
Chow, J.W.3
-
48
-
-
34548138992
-
Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections
-
Parkins M.D., Sabuda D.M., Elsayed S., et al. Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections. J Antimicrob Chemother 60 (2007) 613-618
-
(2007)
J Antimicrob Chemother
, vol.60
, pp. 613-618
-
-
Parkins, M.D.1
Sabuda, D.M.2
Elsayed, S.3
-
49
-
-
0032765996
-
Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia
-
[comment]
-
Byl B., Clevenbergh P., Jacobs F., et al. Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. [comment]. Clin Infect Dis 29 (1999) 60-66
-
(1999)
Clin Infect Dis
, vol.29
, pp. 60-66
-
-
Byl, B.1
Clevenbergh, P.2
Jacobs, F.3
-
50
-
-
43049150444
-
Role of the infectious diseases specialist consultant on the appropriateness of antimicrobial therapy prescription in an intensive care unit
-
Raineri E., Pan A., Mondello P., et al. Role of the infectious diseases specialist consultant on the appropriateness of antimicrobial therapy prescription in an intensive care unit. Am J Infect Control 36 4 (2008) 283-290
-
(2008)
Am J Infect Control
, vol.36
, Issue.4
, pp. 283-290
-
-
Raineri, E.1
Pan, A.2
Mondello, P.3
-
51
-
-
0032401701
-
Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing
-
Aronin S.I., Peduzzi P., and Quagliarello V.J. Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med 129 (1998) 862-869
-
(1998)
Ann Intern Med
, vol.129
, pp. 862-869
-
-
Aronin, S.I.1
Peduzzi, P.2
Quagliarello, V.J.3
-
52
-
-
0035213049
-
Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center
-
Miner J.R., Heegaard W., Mapes A., et al. Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center. J Emerg Med 21 (2001) 387-392
-
(2001)
J Emerg Med
, vol.21
, pp. 387-392
-
-
Miner, J.R.1
Heegaard, W.2
Mapes, A.3
-
53
-
-
17044414100
-
Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis
-
Proulx N., Frechette D., Toye B., et al. Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. QJM 98 (2005) 291-298
-
(2005)
QJM
, vol.98
, pp. 291-298
-
-
Proulx, N.1
Frechette, D.2
Toye, B.3
-
54
-
-
1642286527
-
Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia
-
Houck P.M., Bratzler D.W., Nsa W., et al. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 164 (2004) 637-644
-
(2004)
Arch Intern Med
, vol.164
, pp. 637-644
-
-
Houck, P.M.1
Bratzler, D.W.2
Nsa, W.3
-
55
-
-
0032437068
-
Delay in administering the first dose of antibiotics in patients admitted to hospital with serious infections
-
Natsch S., Kullberg B.J., Van der Meer J.W., et al. Delay in administering the first dose of antibiotics in patients admitted to hospital with serious infections. Eur J Clin Microbiol Infect Dis 17 10 (1998) 681-684
-
(1998)
Eur J Clin Microbiol Infect Dis
, vol.17
, Issue.10
, pp. 681-684
-
-
Natsch, S.1
Kullberg, B.J.2
Van der Meer, J.W.3
-
56
-
-
0028832117
-
Determination of plasma concentrations of amikacin in patients of an intensive care unit
-
Pimentel F.L., Abelha F., Trigo M.A., et al. Determination of plasma concentrations of amikacin in patients of an intensive care unit. J Chemother 7 (1995) 45-49
-
(1995)
J Chemother
, vol.7
, pp. 45-49
-
-
Pimentel, F.L.1
Abelha, F.2
Trigo, M.A.3
-
57
-
-
0026322390
-
Effect of individualized pharmacokinetic dosing on patient outcome
-
Whipple J.K., Ausman R.K., Franson T., et al. Effect of individualized pharmacokinetic dosing on patient outcome. Crit Care Med 19 (1991) 1480-1485
-
(1991)
Crit Care Med
, vol.19
, pp. 1480-1485
-
-
Whipple, J.K.1
Ausman, R.K.2
Franson, T.3
-
58
-
-
0035112931
-
Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock
-
Joukhadar C., Frossard M., Mayer B.X., et al. Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock. Crit Care Med 29 (2001) 385-391
-
(2001)
Crit Care Med
, vol.29
, pp. 385-391
-
-
Joukhadar, C.1
Frossard, M.2
Mayer, B.X.3
-
59
-
-
0023754003
-
Prospective comparison of traditional and pharmacokinetic aminoglycoside dosing methods
-
Franson T.R., Quebbeman E.J., Whipple J., et al. Prospective comparison of traditional and pharmacokinetic aminoglycoside dosing methods. Crit Care Med 16 (1988) 840-843
-
(1988)
Crit Care Med
, vol.16
, pp. 840-843
-
-
Franson, T.R.1
Quebbeman, E.J.2
Whipple, J.3
-
60
-
-
0036095347
-
Tissue distribution of imipenem in critically ill patients
-
Tegeder I., Schmidtko A., Brautigam L., et al. Tissue distribution of imipenem in critically ill patients. Clin Pharmacol Ther 71 (2002) 325-333
-
(2002)
Clin Pharmacol Ther
, vol.71
, pp. 325-333
-
-
Tegeder, I.1
Schmidtko, A.2
Brautigam, L.3
-
61
-
-
0021364813
-
The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia
-
Moore R.D., Smith C.R., and Lietman P.S. The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia. J Infect Dis 149 (1984) 443-448
-
(1984)
J Infect Dis
, vol.149
, pp. 443-448
-
-
Moore, R.D.1
Smith, C.R.2
Lietman, P.S.3
-
62
-
-
0021221208
-
Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia
-
Moore R.D., Smith C.R., and Lietman P.S. Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia. Am J Med 77 (1984) 657-662
-
(1984)
Am J Med
, vol.77
, pp. 657-662
-
-
Moore, R.D.1
Smith, C.R.2
Lietman, P.S.3
-
63
-
-
0027161344
-
Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients
-
Forrest A., Nix D.E., Ballow C.H., et al. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob Agents Chemother 37 (1993) 1073-1081
-
(1993)
Antimicrob Agents Chemother
, vol.37
, pp. 1073-1081
-
-
Forrest, A.1
Nix, D.E.2
Ballow, C.H.3
-
64
-
-
0032515386
-
Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials
-
Preston S.L., Drusano G.L., Berman A.L., et al. Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials. JAMA 279 (1998) 125-129
-
(1998)
JAMA
, vol.279
, pp. 125-129
-
-
Preston, S.L.1
Drusano, G.L.2
Berman, A.L.3
-
65
-
-
2442549489
-
Relationship between fluoroquinolone area under the curve: minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia
-
Drusano G.L., Preston S.L., Fowler C., et al. Relationship between fluoroquinolone area under the curve: minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia. J Infect Dis 189 (2004) 1590-1597
-
(2004)
J Infect Dis
, vol.189
, pp. 1590-1597
-
-
Drusano, G.L.1
Preston, S.L.2
Fowler, C.3
-
66
-
-
0023119430
-
Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration
-
Moore R.D., Lietman P.S., and Smith C.R. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis 155 (1987) 93-99
-
(1987)
J Infect Dis
, vol.155
, pp. 93-99
-
-
Moore, R.D.1
Lietman, P.S.2
Smith, C.R.3
-
67
-
-
0032979927
-
Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria
-
Kashuba A.D., Nafziger A.N., Drusano G.L., et al. Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria. Antimicrobial Agents & Chemotherapy 43 (1999) 623-629
-
(1999)
Antimicrobial Agents & Chemotherapy
, vol.43
, pp. 623-629
-
-
Kashuba, A.D.1
Nafziger, A.N.2
Drusano, G.L.3
-
68
-
-
0021708980
-
Role for dual individualization with cefmenoxime
-
Schentag J.J., Smith I.L., Swanson D.J., et al. Role for dual individualization with cefmenoxime. Am J Med 77 (1984) 43-50
-
(1984)
Am J Med
, vol.77
, pp. 43-50
-
-
Schentag, J.J.1
Smith, I.L.2
Swanson, D.J.3
-
69
-
-
0028785941
-
Once-daily versus multiple-daily dosing of aminoglycosides
-
Craig W.A. Once-daily versus multiple-daily dosing of aminoglycosides. J Chemother 7 Suppl 2 (1995) 47-52
-
(1995)
J Chemother
, vol.7
, Issue.SUPPL. 2
, pp. 47-52
-
-
Craig, W.A.1
-
70
-
-
0031807608
-
Dosing of aminoglycosides to rapidly attain pharmacodynamic goals and hasten therapeutic response by using individualized pharmacokinetic monitoring of patients with pneumonia caused by gram-negative organisms
-
Kashuba A.D., Bertino Jr. J.S., and Nafziger A.N. Dosing of aminoglycosides to rapidly attain pharmacodynamic goals and hasten therapeutic response by using individualized pharmacokinetic monitoring of patients with pneumonia caused by gram-negative organisms. Antimicrobial Agents & Chemotherapy 42 (1998) 1842-1844
-
(1998)
Antimicrobial Agents & Chemotherapy
, vol.42
, pp. 1842-1844
-
-
Kashuba, A.D.1
Bertino Jr., J.S.2
Nafziger, A.N.3
-
71
-
-
0023920993
-
Cure of Pseudomonas aeruginosa infection in neutropenic patients by continuous infusion of ceftazidime
-
Daenen S., and Vries-Hospers H. Cure of Pseudomonas aeruginosa infection in neutropenic patients by continuous infusion of ceftazidime. Lancet 1 (1988) 937
-
(1988)
Lancet
, vol.1
, pp. 937
-
-
Daenen, S.1
Vries-Hospers, H.2
-
72
-
-
0036776275
-
Continuous infusion of ceftazidime for patients with breast cancer and multiple myeloma receiving high-dose chemotherapy and peripheral blood stem cell transplantation
-
Egerer G., Goldschmidt H., Hensel M., et al. Continuous infusion of ceftazidime for patients with breast cancer and multiple myeloma receiving high-dose chemotherapy and peripheral blood stem cell transplantation. Bone Marrow Transplant 30 (2002) 427-431
-
(2002)
Bone Marrow Transplant
, vol.30
, pp. 427-431
-
-
Egerer, G.1
Goldschmidt, H.2
Hensel, M.3
-
73
-
-
0030067765
-
Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections
-
Benko A.S., Cappelletty D.M., Kruse J.A., et al. Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections. Antimicrobial Agents & Chemotherapy 40 (1996) 691-695
-
(1996)
Antimicrobial Agents & Chemotherapy
, vol.40
, pp. 691-695
-
-
Benko, A.S.1
Cappelletty, D.M.2
Kruse, J.A.3
-
74
-
-
0345130000
-
Continuous infusion versus intermittent administration of meropenem in critically ill patients
-
Thalhammer F., Traunmuller F., El M., et al. Continuous infusion versus intermittent administration of meropenem in critically ill patients. J Antimicrob Chemother 43 (1999) 523-527
-
(1999)
J Antimicrob Chemother
, vol.43
, pp. 523-527
-
-
Thalhammer, F.1
Traunmuller, F.2
El, M.3
-
75
-
-
0035141347
-
Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock
-
Sfeir T., Saha D.C., Astiz M., et al. Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock. Crit Care Med 29 (2001) 129-133
-
(2001)
Crit Care Med
, vol.29
, pp. 129-133
-
-
Sfeir, T.1
Saha, D.C.2
Astiz, M.3
-
76
-
-
0031943481
-
Monocyte function before and after surgical trauma
-
Haupt W., Riese J., Mehler C., et al. Monocyte function before and after surgical trauma. Dig Surg 15 (1998) 102-104
-
(1998)
Dig Surg
, vol.15
, pp. 102-104
-
-
Haupt, W.1
Riese, J.2
Mehler, C.3
-
77
-
-
0030036614
-
Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes
-
Brandtzaeg P., Osnes L., Ovstebo R., et al. Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes. J Exp Med 184 (1996) 51-60
-
(1996)
J Exp Med
, vol.184
, pp. 51-60
-
-
Brandtzaeg, P.1
Osnes, L.2
Ovstebo, R.3
-
78
-
-
0031755096
-
Monocyte anergy in septic shock is associated with a predilection to apoptosis and is reversed by granulocyte-macrophage colony-stimulating factor ex vivo
-
Williams M.A., Withington S., Newland A.C., et al. Monocyte anergy in septic shock is associated with a predilection to apoptosis and is reversed by granulocyte-macrophage colony-stimulating factor ex vivo. J Infect Dis 178 (1998) 1421-1433
-
(1998)
J Infect Dis
, vol.178
, pp. 1421-1433
-
-
Williams, M.A.1
Withington, S.2
Newland, A.C.3
-
79
-
-
0036256051
-
Failure of neutrophil chemotactic function in septic patients
-
Tavares-Murta B.M., Zaparoli M., Ferreira R.B., et al. Failure of neutrophil chemotactic function in septic patients. Crit Care Med 30 (2002) 1056-1061
-
(2002)
Crit Care Med
, vol.30
, pp. 1056-1061
-
-
Tavares-Murta, B.M.1
Zaparoli, M.2
Ferreira, R.B.3
-
80
-
-
0036392072
-
Phagocytosis by emigrated, intra-abdominal neutrophils is depressed during human secondary peritonitis
-
Holzer K., Konietzny P., Wilhelm K., et al. Phagocytosis by emigrated, intra-abdominal neutrophils is depressed during human secondary peritonitis. Eur Surg Res 34 (2002) 275-284
-
(2002)
Eur Surg Res
, vol.34
, pp. 275-284
-
-
Holzer, K.1
Konietzny, P.2
Wilhelm, K.3
-
81
-
-
0033929552
-
Role of nitric oxide in the failure of neutrophil migration in sepsis
-
Benjamim C.F., Ferreira S.H., and Cunha F.Q. Role of nitric oxide in the failure of neutrophil migration in sepsis. J Infect Dis 182 (2000) 214-223
-
(2000)
J Infect Dis
, vol.182
, pp. 214-223
-
-
Benjamim, C.F.1
Ferreira, S.H.2
Cunha, F.Q.3
-
82
-
-
0025865688
-
Monotherapy versus combination antimicrobial therapy: a review
-
Barriere S.L. Monotherapy versus combination antimicrobial therapy: a review. Pharmacotherapy 11 (1991) 64S-71S
-
(1991)
Pharmacotherapy
, vol.11
-
-
Barriere, S.L.1
-
83
-
-
0037087226
-
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
-
Hughes W.T., Armstrong D., Bodey G.P., et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34 (2002) 730-751
-
(2002)
Clin Infect Dis
, vol.34
, pp. 730-751
-
-
Hughes, W.T.1
Armstrong, D.2
Bodey, G.P.3
-
85
-
-
0024387119
-
Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients
-
Hilf M., Yu V.L., Sharp J., et al. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med 87 (1989) 540-546
-
(1989)
Am J Med
, vol.87
, pp. 540-546
-
-
Hilf, M.1
Yu, V.L.2
Sharp, J.3
-
86
-
-
0025938759
-
Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy
-
Chow J.W., Fine M.J., Shlaes D.M., et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 115 (1991) 585-590
-
(1991)
Ann Intern Med
, vol.115
, pp. 585-590
-
-
Chow, J.W.1
Fine, M.J.2
Shlaes, D.M.3
-
87
-
-
0026473059
-
Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy
-
Korvick J.A., Bryan C.S., Farber B., et al. Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy. Antimicrobial Agents & Chemotherapy 36 (1992) 2639-2644
-
(1992)
Antimicrobial Agents & Chemotherapy
, vol.36
, pp. 2639-2644
-
-
Korvick, J.A.1
Bryan, C.S.2
Farber, B.3
-
88
-
-
0017927868
-
Antimicrobial synergism in the therapy of gram-negative rod bacteremia
-
Anderson E.T., Young L.S., and Hewitt W.L. Antimicrobial synergism in the therapy of gram-negative rod bacteremia. Chemotherapy 24 (1978) 45-54
-
(1978)
Chemotherapy
, vol.24
, pp. 45-54
-
-
Anderson, E.T.1
Young, L.S.2
Hewitt, W.L.3
-
89
-
-
4544244010
-
Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia
-
Baddour L.M., Yu V.L., Klugman K.P., et al. Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia. Am J Respir Crit Care Med 170 4 (2004) 440-444
-
(2004)
Am J Respir Crit Care Med
, vol.170
, Issue.4
, pp. 440-444
-
-
Baddour, L.M.1
Yu, V.L.2
Klugman, K.P.3
-
90
-
-
0034890569
-
Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia
-
Waterer G.W., Somes G.W., and Wunderink R.G. Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia. Arch Intern Med 161 (2001) 1837-1842
-
(2001)
Arch Intern Med
, vol.161
, pp. 1837-1842
-
-
Waterer, G.W.1
Somes, G.W.2
Wunderink, R.G.3
-
91
-
-
0037442372
-
Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia
-
Martinez J.A., Horcajada J.P., Almela M., et al. Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 36 (2003) 389-395
-
(2003)
Clin Infect Dis
, vol.36
, pp. 389-395
-
-
Martinez, J.A.1
Horcajada, J.P.2
Almela, M.3
-
92
-
-
34249304464
-
Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock
-
Rodriguez A., Mendia A., Sirvent J.M., et al. Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock. Crit Care Med 35 (2007) 1493-1498
-
(2007)
Crit Care Med
, vol.35
, pp. 1493-1498
-
-
Rodriguez, A.1
Mendia, A.2
Sirvent, J.M.3
-
93
-
-
0029788247
-
International sepsis trial (INTERSEPT): role and impact of a clinical evaluation committee
-
Sprung C.L., Finch R.G., Thijs L.G., et al. International sepsis trial (INTERSEPT): role and impact of a clinical evaluation committee. Crit Care Med 24 (1996) 1441-1447
-
(1996)
Crit Care Med
, vol.24
, pp. 1441-1447
-
-
Sprung, C.L.1
Finch, R.G.2
Thijs, L.G.3
-
94
-
-
0023472263
-
Improved results from a standardized approach in treating patients with necrotizing fasciitis
-
Sudarsky L.A., Laschinger J.C., Coppa G.F., et al. Improved results from a standardized approach in treating patients with necrotizing fasciitis. Ann Surg 206 (1987) 661-665
-
(1987)
Ann Surg
, vol.206
, pp. 661-665
-
-
Sudarsky, L.A.1
Laschinger, J.C.2
Coppa, G.F.3
-
95
-
-
0029820595
-
Necrotizing fasciitis in children: prompt recognition and aggressive therapy improve survival
-
Moss R.L., Musemeche C.A., and Kosloske A.M. Necrotizing fasciitis in children: prompt recognition and aggressive therapy improve survival. J Pediatr Surg 31 (1996) 1142-1146
-
(1996)
J Pediatr Surg
, vol.31
, pp. 1142-1146
-
-
Moss, R.L.1
Musemeche, C.A.2
Kosloske, A.M.3
-
96
-
-
70350578312
-
Outcome of septic shock correlates with duration of hypotension prior to source control implementation
-
Kumar A., Wood K., Gurka D., et al. Outcome of septic shock correlates with duration of hypotension prior to source control implementation. ICAAC Proceedings 350 (2004) K-1222
-
(2004)
ICAAC Proceedings
, vol.350
-
-
Kumar, A.1
Wood, K.2
Gurka, D.3
|